These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25000175)

  • 1. Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients.
    Eryilmaz G; Hizli Sayar G; Özten E; Gül IG; Karamustafalioğlu O; Yorbik Ö
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):288-92. PubMed ID: 25000175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of comedication on the serum levels of aripiprazole: evidence from a routine therapeutic drug monitoring service.
    Castberg I; Spigset O
    Pharmacopsychiatry; 2007 May; 40(3):107-10. PubMed ID: 17541885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
    Citrome L; Josiassen R; Bark N; Salazar DE; Mallikaarjun S
    J Clin Pharmacol; 2005 Jan; 45(1):89-93. PubMed ID: 15601809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of a pharmacokinetic drug-drug interaction between lithium and valproate when co-administered with aripiprazole.
    Boulton DW; Kollia GD; Mallikaarjun S; Kornhauser DM
    J Clin Pharm Ther; 2012 Oct; 37(5):565-70. PubMed ID: 22943745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.
    de Bartolomeis A; Perugi G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2027-36. PubMed ID: 22946707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
    J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial.
    Jeong HG; Lee MS; Ko YH; Han C; Jung IK
    Clin Neuropharmacol; 2012; 35(3):97-102. PubMed ID: 22592508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aripiprazole and concomitant carbamazepine.
    Citrome L; Macher JP; Salazar DE; Mallikaarjun S; Boulton DW
    J Clin Psychopharmacol; 2007 Jun; 27(3):279-83. PubMed ID: 17502775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: an open-label, parallel-arm, multiple-dose study.
    Mallikaarjun S; Kane JM; Bricmont P; McQuade R; Carson W; Sanchez R; Forbes RA; Fleischhacker WW
    Schizophr Res; 2013 Oct; 150(1):281-8. PubMed ID: 23890595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose manic switch and high-dose antimanic effect and extrapyramidal symptoms by aripiprazole in a single bipolar patient.
    Park YM
    Am J Ther; 2014; 21(6):e218-20. PubMed ID: 23676345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
    Spina E; D'Arrigo C; Santoro V; Muscatello MR; Pandolfo G; Zoccali R; Diaz FJ; de Leon J
    Ther Drug Monit; 2009 Dec; 31(6):758-63. PubMed ID: 19865002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder.
    Schieber FC; Boulton DW; Balch AH; Croop R; Mallikaarjun S; Benson J; Carlson BX
    Hum Psychopharmacol; 2009 Mar; 24(2):145-52. PubMed ID: 19132712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.
    Kemp DE; De Hert M; Rahman Z; Fyans P; Eudicone JM; Marler SV; Baker RA; Carlson BX
    J Affect Disord; 2013 May; 148(1):84-91. PubMed ID: 23261129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.
    Woo YS; Bahk WM; Chung MY; Kim DH; Yoon BH; Lee JH; Ahn YM; Chung SK; Kim JG; Lee KH; Paik KC
    Hum Psychopharmacol; 2011 Dec; 26(8):543-53. PubMed ID: 22134973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium-valproate maintenance therapy with healthy controls.
    Kurt E; Emul M; Ozbulut O; Guler O; Erdur F; Sağlam H; Gecici O
    J Psychopharmacol; 2009 May; 23(3):328-33. PubMed ID: 18515458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.